| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC3
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 3
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACTG1
|
actin gamma 1
|
|
ACVR1
|
activin A receptor, type I
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
|
ADCY5
|
adenylate cyclase 5
|
|
ADD1
|
adducin 1 (alpha)
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADORA3
|
adenosine A3 receptor
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGGF1
|
angiogenic factor with G patch and FHA domains 1
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ALS2
|
amyotrophic lateral sclerosis 2 (juvenile)
|
|
ANGPT1
|
angiopoietin 1
|
|
API5
|
apoptosis inhibitor 5
|
|
APLN
|
apelin
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APOL1
|
apolipoprotein L, 1
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP4
|
aquaporin 4
|
|
AR
|
androgen receptor
|
|
ARF1
|
ADP-ribosylation factor 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP4B
|
ATPase, H+/K+ exchanging, beta polypeptide
|
|
ATR
|
ATR serine/threonine kinase
|
|
ATXN2
|
ataxin 2
|
|
AURKB
|
aurora kinase B
|
|
AZU1
|
azurocidin 1
|
|
B2M
|
beta-2-microglobulin
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAG6
|
BCL2-associated athanogene 6
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L10
|
BCL2-like 10 (apoptosis facilitator)
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCLAF1
|
BCL2-associated transcription factor 1
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BRCA2
|
breast cancer 2, early onset
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CACNA1G
|
calcium channel, voltage-dependent, T type, alpha 1G subunit
|
|
CARTPT
|
CART prepropeptide
|
|
CASP2
|
caspase 2, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP4
|
caspase 4, apoptosis-related cysteine peptidase
|
|
CASP6
|
caspase 6, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBLL1
|
Cbl proto-oncogene-like 1, E3 ubiquitin protein ligase
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL26
|
chemokine (C-C motif) ligand 26
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCL7
|
chemokine (C-C motif) ligand 7
|
|
CCND2
|
cyclin D2
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CD163
|
CD163 molecule
|
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4
|
|
CD28
|
CD28 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD4
|
CD4 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CD80
|
CD80 molecule
|
|
CD83
|
CD83 molecule
|
|
CD86
|
CD86 molecule
|
|
CD8A
|
CD8a molecule
|
|
CDC42
|
cell division cycle 42
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CHD5
|
chromodomain helicase DNA binding protein 5
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHIT1
|
chitinase 1 (chitotriosidase)
|
|
CISD1
|
CDGSH iron sulfur domain 1
|
|
CKM
|
creatine kinase, muscle
|
|
CLEC7A
|
C-type lectin domain family 7, member A
|
|
CLIP3
|
CAP-GLY domain containing linker protein 3
|
|
CNBP
|
CCHC-type zinc finger, nucleic acid binding protein
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREB3
|
cAMP responsive element binding protein 3
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
CYTH2
|
cytohesin 2
|
|
DAXX
|
death-domain associated protein
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DEDD
|
death effector domain containing
|
|
DHX58
|
DEXH (Asp-Glu-X-His) box polypeptide 58
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DIRAS3
|
DIRAS family, GTP-binding RAS-like 3
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DNM1L
|
dynamin 1-like
|
|
DROSHA
|
drosha, ribonuclease type III
|
|
DSP
|
desmoplakin
|
|
DUOX2
|
dual oxidase 2
|
|
DYNLT1
|
dynein, light chain, Tctex-type 1
|
|
DYSF
|
dysferlin
|
|
EDN1
|
endothelin 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EP300
|
E1A binding protein p300
|
|
EPHB1
|
EPH receptor B1
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
EREG
|
epiregulin
|
|
ESRRA
|
estrogen-related receptor alpha
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
EXOC1
|
exocyst complex component 1
|
|
EXOC4
|
exocyst complex component 4
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F9
|
coagulation factor IX
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FCER1A
|
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCRL3
|
Fc receptor-like 3
|
|
FERMT3
|
fermitin family member 3
|
|
FGF10
|
fibroblast growth factor 10
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FKBP5
|
FK506 binding protein 5
|
|
FLCN
|
folliculin
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXP1
|
forkhead box P1
|
|
FPR1
|
formyl peptide receptor 1
|
|
FPR2
|
formyl peptide receptor 2
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FUS
|
FUS RNA binding protein
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GFER
|
growth factor, augmenter of liver regeneration
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GLTP
|
glycolipid transfer protein
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GOLM1
|
golgi membrane protein 1
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GPLD1
|
glycosylphosphatidylinositol specific phospholipase D1
|
|
GPR39
|
G protein-coupled receptor 39
|
|
GPR4
|
G protein-coupled receptor 4
|
|
GRID2
|
glutamate receptor, ionotropic, delta 2
|
|
GRM1
|
glutamate receptor, metabotropic 1
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GZMK
|
granzyme K (granzyme 3; tryptase II)
|
|
H2AFX
|
H2A histone family, member X
|
|
HBB
|
hemoglobin, beta
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HCK
|
HCK proto-oncogene, Src family tyrosine kinase
|
|
HCLS1
|
hematopoietic cell-specific Lyn substrate 1
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HK1
|
hexokinase 1
|
|
HK2
|
hexokinase 2
|
|
HLA-DRA
|
major histocompatibility complex, class II, DR alpha
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGB1
|
high mobility group box 1
|
|
HPCA
|
hippocalcin
|
|
HRC
|
histidine rich calcium binding protein
|
|
HTN3
|
histatin 3
|
|
HTRA2
|
HtrA serine peptidase 2
|
|
HTT
|
huntingtin
|
|
ICOSLG
|
inducible T-cell co-stimulator ligand
|
|
ID3
|
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL2
|
interleukin 2
|
|
IL20
|
interleukin 20
|
|
IL27
|
interleukin 27
|
|
IL33
|
interleukin 33
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
INSIG1
|
insulin induced gene 1
|
|
INSIG2
|
insulin induced gene 2
|
|
IQGAP1
|
IQ motif containing GTPase activating protein 1
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF7
|
interferon regulatory factor 7
|
|
IRS1
|
insulin receptor substrate 1
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB3BP
|
integrin beta 3 binding protein (beta3-endonexin)
|
|
ITGB6
|
integrin, beta 6
|
|
ITGB8
|
integrin, beta 8
|
|
ITPR1
|
inositol 1,4,5-trisphosphate receptor, type 1
|
|
ITPR3
|
inositol 1,4,5-trisphosphate receptor, type 3
|
|
JAG1
|
jagged 1
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
KARS
|
lysyl-tRNA synthetase
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KCNK3
|
potassium channel, two pore domain subfamily K, member 3
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCTD8
|
potassium channel tetramerization domain containing 8
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRIT1
|
KRIT1, ankyrin repeat containing
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS8
|
lectin, galactoside-binding, soluble, 8
|
|
LMNA
|
lamin A/C
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRRK1
|
leucine-rich repeat kinase 1
|
|
LTA
|
lymphotoxin alpha
|
|
LY6D
|
lymphocyte antigen 6 complex, locus D
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MACC1
|
metastasis associated in colon cancer 1
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP3K15
|
mitogen-activated protein kinase kinase kinase 15
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAP4
|
microtubule-associated protein 4
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCM10
|
minichromosome maintenance complex component 10
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MEF2A
|
myocyte enhancer factor 2A
|
|
MEF2B
|
myocyte enhancer factor 2B
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MEP1A
|
meprin A, alpha (PABA peptide hydrolase)
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MIR101-1
|
microRNA 101-1
|
|
MIR145
|
microRNA 145
|
|
MIR210
|
microRNA 210
|
|
MIR29B1
|
microRNA 29b-1
|
|
MIR449A
|
microRNA 449a
|
|
MIR451A
|
microRNA 451a
|
|
MIR548M
|
microRNA 548m
|
|
MLLT11
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11
|
|
MLXIP
|
MLX interacting protein
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MTMR3
|
myotubularin related protein 3
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYOG
|
myogenin (myogenic factor 4)
|
|
NBN
|
nibrin
|
|
NCR3
|
natural cytotoxicity triggering receptor 3
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOTCH1
|
notch 1
|
|
NOTCH3
|
notch 3
|
|
NOV
|
nephroblastoma overexpressed
|
|
NPC1
|
Niemann-Pick disease, type C1
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTS
|
neurotensin
|
|
OGT
|
O-linked N-acetylglucosamine (GlcNAc) transferase
|
|
OTC
|
ornithine carbamoyltransferase
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY1
|
purinergic receptor P2Y, G-protein coupled, 1
|
|
P2RY13
|
purinergic receptor P2Y, G-protein coupled, 13
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PCDH19
|
protocadherin 19
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PLG
|
plasminogen
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
|
PML
|
promyelocytic leukemia
|
|
PNLIP
|
pancreatic lipase
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like
|
|
PPP4R1
|
protein phosphatase 4, regulatory subunit 1
|
|
PRDX3
|
peroxiredoxin 3
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKD1
|
protein kinase D1
|
|
PRKD2
|
protein kinase D2
|
|
PRLR
|
prolactin receptor
|
|
PRMT1
|
protein arginine methyltransferase 1
|
|
PSEN1
|
presenilin 1
|
|
PTN
|
pleiotrophin
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPRJ
|
protein tyrosine phosphatase, receptor type, J
|
|
RAB4A
|
RAB4A, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RB1
|
retinoblastoma 1
|
|
RBCK1
|
RanBP-type and C3HC4-type zinc finger containing 1
|
|
REST
|
RE1-silencing transcription factor
|
|
RFWD2
|
ring finger and WD repeat domain 2, E3 ubiquitin protein ligase
|
|
RHO
|
rhodopsin
|
|
RHOA
|
ras homolog family member A
|
|
RNASE3
|
ribonuclease, RNase A family, 3
|
|
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)
|
|
ROMO1
|
reactive oxygen species modulator 1
|
|
RTL1
|
retrotransposon-like 1
|
|
RUSC2
|
RUN and SH3 domain containing 2
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
SAR1A
|
secretion associated, Ras related GTPase 1A
|
|
SELE
|
selectin E
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SELPLG
|
selectin P ligand
|
|
SENP1
|
SUMO1/sentrin specific peptidase 1
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SH2B3
|
SH2B adaptor protein 3
|
|
SIRT1
|
sirtuin 1
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLAMF1
|
signaling lymphocytic activation molecule family member 1
|
|
SLC1A1
|
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC9A3
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SMAD2
|
SMAD family member 2
|
|
SMC1A
|
structural maintenance of chromosomes 1A
|
|
SMPD3
|
sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II)
|
|
SNAI2
|
snail family zinc finger 2
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SP1
|
Sp1 transcription factor
|
|
SPHK1
|
sphingosine kinase 1
|
|
SQSTM1
|
sequestosome 1
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SREBF2
|
sterol regulatory element binding transcription factor 2
|
|
SRI
|
sorcin
|
|
SSH2
|
slingshot protein phosphatase 2
|
|
ST6GAL1
|
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STAU1
|
staufen double-stranded RNA binding protein 1
|
|
STIL
|
SCL/TAL1 interrupting locus
|
|
STIM1
|
stromal interaction molecule 1
|
|
STPG1
|
sperm-tail PG-rich repeat containing 1
|
|
SYK
|
spleen tyrosine kinase
|
|
TAB1
|
TGF-beta activated kinase 1/MAP3K7 binding protein 1
|
|
TACR1
|
tachykinin receptor 1
|
|
TERF2
|
telomeric repeat binding factor 2
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TLR10
|
toll-like receptor 10
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLR7
|
toll-like receptor 7
|
|
TLR8
|
toll-like receptor 8
|
|
TMEM173
|
transmembrane protein 173
|
|
TMSB4X
|
thymosin beta 4, X-linked
|
|
TNF
|
tumor necrosis factor
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
|
TP53
|
tumor protein p53
|
|
TRA
|
T cell receptor alpha locus
|
|
TRAF2
|
TNF receptor-associated factor 2
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TRIP13
|
thyroid hormone receptor interactor 13
|
|
TRPC1
|
transient receptor potential cation channel, subfamily C, member 1
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TRPV2
|
transient receptor potential cation channel, subfamily V, member 2
|
|
TSC2
|
tuberous sclerosis 2
|
|
TXNIP
|
thioredoxin interacting protein
|
|
ULK1
|
unc-51 like autophagy activating kinase 1
|
|
USP18
|
ubiquitin specific peptidase 18
|
|
USP2
|
ubiquitin specific peptidase 2
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VCAN
|
versican
|
|
VDAC1
|
voltage-dependent anion channel 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
YAP1
|
Yes-associated protein 1
|
|
ZBP1
|
Z-DNA binding protein 1
|
